Inhibition of allergic reactions by a novel phenanthroline ICI 74,917.
D000818:Animals; D000937:Antigen-Antibody Reactions / Q000187:drug effects; D001986:Bronchial Spasm / Q000188:drug therapy; D004205:Cromolyn Sodium / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004353:Drug Evaluation, Preclinical; D006168:Guinea Pigs; D006636:Histamine Release / Q000187:drug effects; D006801:Humans; D006967:Hypersensitivity / Q000188:drug therapy; D007108:Immune Tolerance / Q000187:drug effects*; D007073:Immunoglobulin E; D007166:Immunosuppressive Agents; D008407:Mast Cells / Q000187:drug effects; D051379:Mice; D010323:Passive Cutaneous Anaphylaxis / Q000187:drug effects*; D010618:Phenanthrolines / Q000494:pharmacology* / Q000627:therapeutic use; D011817:Rabbits; D051381:Rats
D007166:Immunosuppressive Agents; D010618:Phenanthrolines; D007073:Immunoglobulin E; D004205:Cromolyn Sodium